{"transactions":[{"id":858325,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62546,"kind":"person","name":"Leupin Nicolas","position":1,"cik":"0002007766","reported_name":"Leupin Nicolas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:33:41.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":1100,"price":13.3054,"value":14635.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price."}],"balance_after":102979,"source":{"system":"sec-edgar","filing":"0002007766-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000200776626000003/primarydocument.xml","form_type":"4"}},{"id":867067,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62546,"kind":"person","name":"Leupin Nicolas","position":1,"cik":"0002007766","reported_name":"Leupin Nicolas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:09:55.000Z","date":"2026-02-27","kind":"sale","planned":false,"acquired":false,"shares":1029,"price":13.6638,"value":14060.0502,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.45 USD to $13.97 USD; the price reported above reflects the weighted average sale price."}],"balance_after":104079,"source":{"system":"sec-edgar","filing":"0002007766-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000200776626000002/primarydocument.xml","form_type":"4"}},{"id":1219533,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62546,"kind":"person","name":"Leupin Nicolas","position":1,"cik":"0002007766","reported_name":"Leupin Nicolas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-03-06T21:42:11.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":81499,"price":18.19,"value":1482466.81,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 81,499 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates."}],"balance_after":81499,"derivative":{"exercise_price":18.19,"exercise_date":"2026-03-04","expiration_date":"2035-03-03","underlying":"Ordinary Shares","underlying_shares":81499},"source":{"system":"sec-edgar","filing":"0001562180-25-002163","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025002163/primarydocument.xml","form_type":"4"}},{"id":1219532,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62546,"kind":"person","name":"Leupin Nicolas","position":1,"cik":"0002007766","reported_name":"Leupin Nicolas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:42:11.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":54975,"price":18.19,"value":999995.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates."}],"balance_after":105108,"source":{"system":"sec-edgar","filing":"0001562180-25-002163","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025002163/primarydocument.xml","form_type":"4"}},{"id":1235733,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62546,"kind":"person","name":"Leupin Nicolas","position":1,"cik":"0002007766","reported_name":"Leupin Nicolas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T02:26:14.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":161,"price":20.549,"value":3308.389,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On the transaction date, the reporting person sold 161 shares in multiple trades at prices ranging from $20.41 to $20.85.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":50133,"source":{"system":"sec-edgar","filing":"0001562180-25-001913","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025001913/primarydocument.xml","form_type":"4/A","original_submission_date":"2025-03-03"}},{"id":1235732,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62546,"kind":"person","name":"Leupin Nicolas","position":1,"cik":"0002007766","reported_name":"Leupin Nicolas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T02:26:14.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":830,"price":19.9219,"value":16535.177,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 27, 2025, the reporting person sold 830 shares in multiple trades at prices ranging from $19.41 to $20.4033.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":50294,"source":{"system":"sec-edgar","filing":"0001562180-25-001913","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025001913/primarydocument.xml","form_type":"4/A","original_submission_date":"2025-03-03"}},{"id":1235731,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62546,"kind":"person","name":"Leupin Nicolas","position":1,"cik":"0002007766","reported_name":"Leupin Nicolas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T21:28:11.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":161,"price":20.549,"value":3308.389,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 27, 2025, the reporting person sold 161 shares in multiple trades at prices ranging from $20.41 to $20.85.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":50133,"source":{"system":"sec-edgar","filing":"0001562180-25-001836","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025001836/primarydocument.xml","form_type":"4"}},{"id":1235730,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62546,"kind":"person","name":"Leupin Nicolas","position":1,"cik":"0002007766","reported_name":"Leupin Nicolas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T21:28:11.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":830,"price":19.9219,"value":16535.177,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 27, 2025, the reporting person sold 830 shares in multiple trades at prices ranging from $19.41 to $20.4033.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":50294,"source":{"system":"sec-edgar","filing":"0001562180-25-001836","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025001836/primarydocument.xml","form_type":"4"}},{"id":1609991,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62546,"kind":"person","name":"Leupin Nicolas","position":1,"cik":"0002007766","reported_name":"Leupin Nicolas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2024-02-29T21:33:26.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":78174,"price":16.3,"value":1274236.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 78,174 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates."}],"balance_after":78174,"derivative":{"exercise_price":16.3,"exercise_date":"2025-02-27","expiration_date":"2034-02-26","underlying":"Ordinary Shares","underlying_shares":78174},"source":{"system":"sec-edgar","filing":"0001562180-24-001985","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024001985/primarydocument.xml","form_type":"4"}},{"id":1609990,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62546,"kind":"person","name":"Leupin Nicolas","position":1,"cik":"0002007766","reported_name":"Leupin Nicolas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2024-02-29T21:33:26.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":51124,"price":16.3,"value":833321.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates."}],"balance_after":51124,"source":{"system":"sec-edgar","filing":"0001562180-24-001985","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024001985/primarydocument.xml","form_type":"4"}}]}